All Articles Tagged With: "Defective Drug"
Articles
FDA Drug Safety Monitoring No Better 3 Years Following Vioxx Recall: Report
A new report by the Government Accountability Office (GAO) indicates that the FDA has made little progress in its oversight of post-market drug safety, despite federal recommendations made in 2006. The agency’s drug safety monitoring came under closer scrutiny in the wake of the 2004 recall of the pain medication, Vioxx.
FDA Oversight of Unproven Drugs is Lacking: Government Report
A new congressional report from the Government Accountability Office (GAO) indicates that the FDA has failed to follow up on unproven drugs that are put on the market through an accelerated approval process, and has no mechanism in place to remove those drugs when they prove to be unsuccessful or dangerous.
